Raoul Fisser was named a Qualified Person (QP) to the Quality Affairs team of SynCo Bio Partners. Mr. Fisser joined the Netherlands-based company from Astellas Pharma where he worked in Pharmaceutical Development, having previously gained experience in the QA Department of the largest manufacturing site of Yamanouchi in Japan. He will now support SynCo’s existing QP, Rob Sprenkels, in the release of GMP batches of recombinant protein, polysaccharide and live-microbial-based bulk drug substances and final product. This addition reflects SynCo’s growing client base and the solid business it has established, according to a company statement.

“Raoul is an excellent addition to SynCo’s Quality Affairs team and this expansion demonstrates the continuous growth in both client base and batch production at SynCo since our inception in 2000.Going forward, we look to supporting our clients in GMP production of an even wider range of novel biopharmaceuticals.” commented Pierre Warffemius, the company’s chief executive officer.

SynCo recently expanded the number of clinical and commercial biopharmaceutical batches it is capable of releasing annually. Theexpansion in batch release capabilities will allow SynCo to continue to grow revenues and to increase the number of GMP biopharmaceutical batches it can release each year, the company reported.